Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 2
1992 2
1993 2
1994 2
1995 1
1996 3
1997 2
1998 1
1999 1
2000 3
2001 2
2002 10
2003 3
2004 5
2005 12
2006 6
2007 4
2008 2
2009 1
2010 3
2011 4
2012 3
2013 4
2014 3
2015 4
2016 3
2017 5
2018 4
2019 3
2020 5
2021 3
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
High-Throughput Firefly Luciferase Reporter Assays.
Siebring-van Olst E, van Beusechem VW. Siebring-van Olst E, et al. Among authors: van beusechem vw. Methods Mol Biol. 2018;1755:19-29. doi: 10.1007/978-1-4939-7724-6_2. Methods Mol Biol. 2018. PMID: 29671260
Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies.
van Putten EHP, Kleijn A, van Beusechem VW, Noske D, Lamers CHJ, de Goede AL, Idema S, Hoefnagel D, Kloezeman JJ, Fueyo J, Lang FF, Teunissen CE, Vernhout RM, Bakker C, Gerritsen W, Curiel DT, Vulto A, Lamfers MLM, Dirven CMF. van Putten EHP, et al. Among authors: van beusechem vw. Clin Cancer Res. 2022 Apr 14;28(8):1572-1585. doi: 10.1158/1078-0432.CCR-21-3324. Clin Cancer Res. 2022. PMID: 35176144 Free PMC article. Clinical Trial.
Arming oncolytic viruses to leverage antitumor immunity.
de Gruijl TD, Janssen AB, van Beusechem VW. de Gruijl TD, et al. Among authors: van beusechem vw. Expert Opin Biol Ther. 2015 Jul;15(7):959-71. doi: 10.1517/14712598.2015.1044433. Epub 2015 May 10. Expert Opin Biol Ther. 2015. PMID: 25959450 Review.
Evaluation of a Novel Oncolytic Adenovirus Silencing SYVN1.
Vermeulen C, Brachtlova T, Tol N, van der Meulen-Muileman IH, Hodzic J, van de Vrugt HJ, van Beusechem VW. Vermeulen C, et al. Among authors: van beusechem vw. Int J Mol Sci. 2022 Dec 6;23(23):15430. doi: 10.3390/ijms232315430. Int J Mol Sci. 2022. PMID: 36499754 Free PMC article.
Genetic targeting of adenoviral vectors.
Krasnykh VN, Douglas JT, van Beusechem VW. Krasnykh VN, et al. Among authors: van beusechem vw. Mol Ther. 2000 May;1(5 Pt 1):391-405. doi: 10.1006/mthe.2000.0062. Mol Ther. 2000. PMID: 10933960 Free article. Review. No abstract available.
Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens.
Meliopoulos VA, Andersen LE, Birrer KF, Simpson KJ, Lowenthal JW, Bean AG, Stambas J, Stewart CR, Tompkins SM, van Beusechem VW, Fraser I, Mhlanga M, Barichievy S, Smith Q, Leake D, Karpilow J, Buck A, Jona G, Tripp RA. Meliopoulos VA, et al. Among authors: van beusechem vw. FASEB J. 2012 Apr;26(4):1372-86. doi: 10.1096/fj.11-193466. Epub 2012 Jan 12. FASEB J. 2012. PMID: 22247330 Free PMC article. Review.
Oncolytic adenoviruses for treatment of brain tumours.
Dirven CM, van Beusechem VW, Lamfers ML, Grill J, Gerritsen WR, Vandertop WP. Dirven CM, et al. Among authors: van beusechem vw. Expert Opin Biol Ther. 2002 Dec;2(8):943-52. doi: 10.1517/14712598.2.8.943. Expert Opin Biol Ther. 2002. PMID: 12517272 Review.
111 results